http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2078816-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_601697811fdd1987f2cf7d6e31b1bff2 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00 |
| filingDate | 1987-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1997-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcb1ae2d31b812fd690686d7772554e2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00c82ee82d4f45363ce7186183906386 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c0976dd6dcfb6ca42eca3c4d773791c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ce2c97e233487d075100a6c18af71a3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af84fb757daf332690211c03192f314a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c97047e35eff8c8b7e21ed4bd6bba87f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f54bbb6b86c1af046e6f560a71e4db2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d447d8b1e7bf63d3f065b699c25fb2c |
| publicationDate | 1997-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2078816-C1 |
| titleOfInvention | Method of preparing the inactivated vaccine for prophylaxis of venezuelan encephalomyelitis |
| abstract | FIELD: medicine, virology. SUBSTANCE: virus Venezuelan equine encephalomyelitis cm - 27 ГКВ N 684 is cultured, inactivated with formalin and heat, concentrated and purified by methods of differential and zonal centrifugation. Ready vaccine is sterile, concentrated and purified virion suspension (40-55 mcg/ml) in saline solution (0.14-0.15 NaCl) buffered with tris-buffer (0.01-0.013 M), pH = 7.8-7.9, and containing 0.04-0.05% human albumin as stabilizing agent. Preparation is sorbed on aluminium hydroxide. Vaccine is harmless, nonreactive and nontoxic. Minimal immunizing dose of preparation for white mice does not exceed 0.01 ml. Seroconversion is 98%, not less. EFFECT: improved method of preparing, enhanced effectiveness. 3 tbl |
| priorityDate | 1987-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.